Abstract
20635 Background: Adjuvant anthracyclines-based chemotherapy is effective in EBC to improve the disease-free survival. The initial aim of this study was to assess the QOL of long-term survivors of early breast cancer, especially with regards to anthracycline therapy. Methods: Questionnaires were sent to women of one French hospital who had participated in two randomized trials comparing anthracyclines (CT group) with no chemotherapy (control group) in EBC, and who had no recurrence. Three self-evaluation QOL instruments were used (SF-36, QLQ-C30 and BR23) to compare QOL between the two treatment arms, and with the French general population. Comparisons with the French norms were standardised on sex and age. We selected a priori some scales of interest. All comparisons were made with a p value of 0.01. Results: 932 patients had been enrolled in the primary trials. Among them, 552 were eligible and 155 completed the questionnaires (77 patients in the CT group, 78 in the control group), 14 years on average a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
